Kindred Biosciences (KIN) Tops Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. CVS
10. SPY

Go back to Kindred Biosciences (KIN) Tops Q2 EPS by 7c

Kindred Biosciences Announces Second Quarter 2016 Financial Results

August 8, 2016 4:01 PM EDT

SAN FRANCISCO, Aug. 8, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the second quarter ended June 30, 2016 and provided updates on its programs.  

"We are on track to launch our two lead product candidates by the first half of next year, and transition to revenue generation less than five years after KindredBio was founded. During the quarter we advanced Mirataz, mirtazapine transdermal gel (formerly known as KIND-010), for the management of weight loss in cats, reporting... More